De-Prescribing Proton Pump Inhibitors in Patients With End Stage Kidney Disease: A Quality Improvement Project

BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed and may be associated with harm; hypomagnesemia and reduced effectiveness of calcium carbonate phosphate binders may be important in end-stage kidney disease (ESKD). OBJECTIVES: Our objectives included (1) discontinuing PPIs and H2 bloc...

Descripción completa

Detalles Bibliográficos
Autores principales: Czikk, Daniel, Parpia, Yasin, Roberts, Katelyn, Jain, Gaurav, Vu, Dan-Cung, Zimmerman, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Clinical Research Quantitative
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243371/
https://www.ncbi.nlm.nih.gov/pubmed/35782023
http://dx.doi.org/10.1177/20543581221106244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243371/
https://www.ncbi.nlm.nih.gov/pubmed/35782023
http://dx.doi.org/10.1177/20543581221106244

Ejemplares similares